Therapeutic activities of theophylline in chronic obstructive pulmonary disease

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 3, 1998, Pages 53-56

  Peleman, R A ^a   Kips, J C ^a   Pauwels, R A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE PROLIFERATION; MAST CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LUNG DISEASES, OBSTRUCTIVE; MACROPHAGES, ALVEOLAR; MAST CELLS; THEOPHYLLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031926894     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994; 7:579-91.
2. Polson JB, Kazanowski JJ, Goldman AL, Szentivanyi A. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 1978; 5:535-9.
3. Vaz Fragoso CA, Miller MA. Review of the clinical efficacy of theophylline in the treatment of chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 147:S40-S47.
4. Matthys H, Wastag E, Daikeler G, Kohler D. The influence of aminophylline and pindolol on the mucociliary clearance in patients with chronic bronchitis. Br J Clin Pract 1983; 23S:10-5.
5. Sutton PP, Pavia D, Bateman JRM, Clarke SW. The effect of oral aminophylline on lung mucociliary clearance in man. Chest 1981; 80S:889-92.
6. Pearson MG, Ahmad D, Chamberlain MJ, Morgan WKC, Vinitski S. Aminophylline and mucociliary clearance in patients with irreversible airflow limitation. Br J Clin Pharmacol 1985; 20:688-90.
7. Lakshminarayan S, Sahn SA, Weil JV. Effect of aminophylline on ventilatory responses in normal man. Am Rev Respir Dis 1978; 117:33-8.
8. Saunders JS, Berman TM, Bartlett MM, Kronenberg RS. Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest 1980; 78:279-82.
9. Rochester DF. Respiratory disease: attention turns to the pump. Am J Med 1990; 68:803-5.
10. Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline improves diaphragm contractility. N Engl J Med 1981; 305:249-52.
11. Murciano D, Aubier M, Lecogguic Y, Pariente R. Effects of theophylline on diaphragmatic strength in patients with chronic obstructive pulmonary disease. N Engl J Med 1984; 311:349-53.
12. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri L. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143:138-43.
13. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T lymphocytes and activated eosinophils in asthma and cystic fibrosis. Am Rev Respir Dis 1991; 145:1477-82.
14. Saetta M, Di Stefano A, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.
15. Mullen JBM, Wright JL, Wiggs BR, Pare PD, Hogg JC. Reassessment of inflammation of airways in chronic bronchitis. Br Med J 1985; 291:1235-9.
16. Jeffery PK. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1152-8.
17. Keatings VM, Collins PD, Scott D, Barnes P. Differences in interleukin-8 and tumor necrosis factor in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-4.
18. Kips JC, Enander I, Rytillä PH, Peleman RA, Pauwels RA. Cell specific markers in sputum of COPD patients. Am J Respir Crit Care Med 1996; 153:A821.
19. Welton AF, Simko BA. Regulatory role of adenosine in antigen-induced histamine release from the lung tissue of actively sensitized guinea-pigs. Biochem Pharmacol 1980; 29:1085-92.
20. Calhoun WJ, Stevens CA, Lambert SB. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 1991; 117:514-22.
21. Hatzelmann A, Tenor H, Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br J Pharmacol 1995; 114:821-31.
22. Pedersen B, Dahl R, Karlstom R, Peterson CG, Venge P. Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 1996; 153:1519-29.
23. Lagente V, Pruniaux MP, Junien JL, Moodley I. Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 1995; 151:1720-4.
24. Limatibul S, Shore A, Dorsch HM, Gelfand E. Theophylline modulation of E-rosette formation: an indicator of T-cell maturation. Clin Exp Immunol 1978; 33:503-13.
25. Mary D, Aussel C, Ferrua B, Fehlman M. Regulation of interleukin-2 synthesis by cAMP in human T-cells. J Immunol 1987; 139:1179-84.
26. Hanckock WW, Pleau ME, Kobzik L. Recombinant granulocyte-macrophage colono-stimulating factor down-regulates expression of IL-2 receptors on human mononuclear phagocytes by induction of prostaglandins. J Immunol 1988; 140:3021-5.
27. Scordamaglia A, Ciprandis G, Ruffoni S et al. Theophylline and the immune response; in vitro and in-vivo effects. Clin Immunol Immunopathol 1988; 48:238-6.
28. Coskey LA, Bitting J, Roth MD. Inhibition of natural killer cell activity by therapeutic levels of theophylline. Am J Respir Cell Mol Biol 1993; 9:659-65.
29. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor (TNF) causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145:332-6.
30. Ghezzi P, Dinarello CA. Il-1 induces IL-, 1.III. Specific inhibition of Il-1 production by IFN-gamma. J Immunol 1988; 140:4238-44.
31. Endres S, Fulle HL, Sinha B et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells. Immunol 1991; 72:56-60.
32. Mascali JJ, Cvietusa P, Negri J, Borish L. Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann Allergy Asthma Immunol 1996; 77:34-8.
33. Yoshimura T, Usami E, Kurita C, Watanabe S, Nakao T, Kobayashi J, Yamazaki F, Nagai H. Effect of theophylline of the production of interleukin-1 beta, tumor necrosis factor-α and interleukin-8 by human peripheral blood mononuclear cells. Biol Pharm Bull 1995; 18:1405-8.
34. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. The Lancet 1994; 343:1006-8.
35. Finnerty JP, Lee C, Wilson S, Madden J, Djukanovic R, Holgate ST. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo- controlled parallel group study. Eur Respir J 1996; 9:1672-7.
36. Kidney J, Dominguez M, Taylor PM et al. Immunomodulation by theophylline in asthma. Am J Respir Crit Care Med 1995; 151:1907-14.